Snakebite poisoning in Latin America and the Caribbean: An integral view from a regional perspective;Envenenamientos por mordeduras de serpientes en América Latina y el Caribe: Una visión integral de carácter regional

Boletin de Malariologia y Salud Ambiental

Volumn 51, Issue 1, 2011, Pages 1-16

  Gutiérrez, José María ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Antivenoms; Envenomings; Latin America and the Caribbean; Prevention; Research; Snakebites; Training

Indexed keywords

EID: 80052221962     PISSN: 16904648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Aguilar I., Guerrero B., Salazar A. M., Girón M. E., Pérez J. C., Sánchez E. E. et al. (2007). Individual venom variability in the South American rattlesnake Crotalus durissus cumanensis. Toxicon. 50: 214-224.
2. a ed. Sarvier, São Paulo, Brasil.
3. Baldo C., Jamora C., Yamanouye N., Zom T. M. & Moura-da-Silva A. M. (2010). Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis. PLoS Negl. Trop. Dis. 4: e727.
4. Benítez J. A., Rifakis P. M., Vargas J. A., Cabaniel G. & Rodríguez-Morales A. J. (2007). Trends in fatal snakebites in Venezuela, 1995-2002. Wilderness Environ. Med. 18: 209-213.
5. Bogarín G., Morais J.F., Yamaguchi I.K., Stephano M.A., Marcelino J.R., Nishikawa A.K. et al. (2000). Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon. 38: 1429-1441.
6. Bolaños R. & Cerdas L. (1978). Venoms of coral snakes (Micrurus spp): report on a multivalent antivenin for the Americas. Bull. Pan Am. Health Organ. 12: 23-27.
7. a Edición. Instituto Clodomiro Picado. San José, Costa Rica.
8. Bon C. (1996). Serum therapy was discovered 100 years ago. pp. 3-9. En: Envenomings and their treatments. Eds. Bon C & Goyffon M. Fondation Marcel Mérieux. Lyon, Francia.
9. Calvete J. J. (2010). Antivenomics and venom phenotyping: A marriage of convenience to address the performance and range of clinical use of antivenoms. Toxicon. 56: 1284-1291.
10. Calvete J. J., Sanz L., Cid P., de la Torre P., Flores-Díaz M., dos Santos M. C. et al. (2010). Snake venomics of the Central American rattlesnake Crotalus simus and the South American Crotalus durissus complex points to neurotoxicity as an adaptive paedomorphic trend along Crotalus dispersal in South America. J. Proteome Res. 9: 528-544.
11. Camey K. U., Velarde D. T. & Sanchez E. F. (2002). Pharmacological characterization and neutralization of the venoms used in the production of Bothropic antivenom in Brazil. Toxicon. 40: 501-509.
12. Campbell J. A. & Lamar W. W. (2004). The Venomous Reptiles of the Western Hemisphere. Cornell University Press. Ithaca, USA
13. Cardoso J. L., Fan H. W., França F. O. S., Jorge M. T., Leite R. P., Nishioka S. A. et al. (1993) Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil. Q. J. Med. 86: 315-25.
14. a edición. Ed. Sarvier. São Paulo, Brasil.
15. Chippaux J. P. (2002) Les envenimations ophidiennes en Guyane Française. Méd. Trop. 62: 177-184.
16. a ed. Sarvier, São Paulo, Brasil.
17. a ed. Sarvier, São Paulo, Brasil.
18. de Roodt A., Dolab J. A., Fernández T., Segre L. & Hajos E. E. (1998). Cross-reactivity and heterologous neutralisation of crotaline antivenoms used in Argentina. Toxicon. 36: 1025-1038.
19. Escalante T., Rucavado A., Fox J. W. & Gutiérrez J. M. (2011). Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases. J. Proteomics. (en prensa).
20. Fan H. W. & Cardoso J. L. (1995) Clinical toxicology of snake bites in South America. pp. 667-688. En: Handbook of Clinical Toxicology of Animal Venoms and Poisons. Eds. Meier J. & White J. CRC Press. Boca Raton, Florida, USA.
21. Fernández P. & Gutiérrez J. M. (2008). Mortality due to snakebite envenomation in Costa Rica (1993-2006). Toxicon. 52: 530-533.
22. Fernández G. P., Segura A., Herrera M., Velasco W., Solano G., Gutiérrez J. M. et al. (2010). Neutralization of Bothrops mattogrossensis snake venom from Bolivia: experimental evaluation of llama and donkey antivenoms produced by caprylic acid precipitation. Toxicon. 55: 642-645.
23. Fernández J., Alape-Girón A., Angulo Y., Sanz, L., Gutiérrez J. M., Calvete J. J. et al. (2011). Venomic and antivenomic analyses of the Central American coral snake, Micrurus nigrocinctus (Elapidae). J. Proteome Res. 10: 1816-1827.
24. Gomez H. F. & Dart R. C. (1995). Clinical toxicology of snakebite in North America. pp. 619-644. En: Handbook of clinical toxicology of animal venoms and poisons. Eds. Meier J. & White J. CRC Press. Boca Raton, Florida, USA.
25. González-Andrade F. & Chippaux J. P. (2010). Snake bite envenomation in Ecuador. Trans. R. Soc. Trop. Med. Hyg. 104: 588-591.
26. Gutiérrez J. M. (2002). Comprendiendo los venenos de serpientes: 50 años de investigaciones en América Latina. Rev. Biol. Trop. 50: 377-394.
27. Gutiérrez J. M. (2009a). Snakebite envenomation in Central America. pp. 491-507. En: Handbook of venoms and toxins of reptiles. Ed. Mackessy S.P. CRC Press, Boca Raton, USA.
28. Gutiérrez J. M. (2009b). Hacia una mayor integración de las ciencias naturales y las ciencias sociales: análisis de un caso relacionado con un problema de salud pública. Trama (Instituto Tecnológico de Costa Rica). 2: 30-38.
29. Gutiérrez J. M. & Sasa M. (2002). Bites and envenomations by colubrid snakes in Mexico and Central America. J. Toxicol. Toxin Rev. 21: 105-115.
30. Gutiérrez J. M. & León G. (2009). Snake Antivenoms. Technological, clinical and public health issues. pp. 393-421. En: Animal toxins: State of the art perspectives in health and biotechnology. Eds. de Lima ME, Pimenta AMC, Martin-Euclaire MF & Zingalli RB. Editora UFMG. Belo Horizonte, Brasil.
31. a ed. Sarvier, São Paulo, Brasil.
32. Gutiérrez J. M., Gené, J. A., Rojas G. & Cerdas L. (1985). Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon. 23: 887-893.
33. Gutiérrez J. M., Rucavado A., Escalante T. & Díaz C. (2005). Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon. 45: 997-1011.
34. Gutiérrez J. M., Theakston R. D. G. & Warrell D. A. (2006). Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med. 3: 5150.
35. Gutiérrez J. M., Higashi H. G., Wen F. H. & Burnouf T. (2007). Strengthening antivenom production in Central and South American public laboratories: report of a workshop. Toxicon. 49: 30-35.
36. Gutiérrez J. M., Lomonte B., León G., Alape-Girón A., Flores-Díaz M., Sanz L. et al. (2009a). Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. J. Proteomics. 72: 165-182.
37. Gutiérrez J. M., Fan H. W., Silvera C.L. & Angulo Y. (2009b). Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop. Toxicon. 53: 625-630.
38. Gutiérrez J. M., Williams D., Fan H. W. & Warrell D. A. (2010). Snakebite envenoming from a global perspective: Towards an integrated approach. Toxicon. 56: 1223-1235.
39. Hansson E., Cuadra S., Oudin A., de Jong K., Stroh E., Torén K. & Albin M. (2010). Mapping snakebite epidemiology in Nicaragua. Pitfalls and possible solutions. PLoS Negl. Trop. Dis. 4: e896.
40. Harrison R. A., Hargreaves A., Wagstaff S. C., Faraguer B. & Lalloo D. G. (2009). Snake envenoming: a disease of poverty. PLoS Negl. Trop. Dis. 3: e569.
41. Hunt P. (2007). Neglected Diseases: A Human Rights Analysis. World Health Organization, Geneva.
42. Instituto Clodomiro Picado (2008). Determinación de Actividades Tóxicas de Venenos de Serpientes y su Neutralización por Antivenenos. Manual de Métodos de Laboratorio. Instituto Clodomiro Picado. San José, Costa Rica.
43. Instituto Clodomiro Picado (2009). El Envenenamiento por Mordedura de Serpiente en Centroamérica. Instituto Clodomiro Picado. San José, Costa Rica.
44. Kasturiratne A., Wickremasinghe A. R., de Silva N., Gunawardena N. K., Pathmeswaran A., Premaratna R. et al. (2008). The global burden of snakebite: a literature analysis and modeling based on regional estimates of envenoming and deaths. PLoS Medicine. 5: e218.
45. Kliksberg B. (2007). América Latina. El caso de la salud pública. pp. 121-185. En: Primero la Gente. Una Mirada desde la Ética del Desarrollo a los Principales Problemas del Mundo Globalizado. Eds. Sen A. & Kliksberg B. Temas, Buenos Aires, Argentina.
46. Larrick J. W., Yost J. A. & Kaplan J. (1978). Snake bite among the Waorani Indians of eastern Ecuador. Trans. R. Soc. Trop. Med. Hyg. 72: 542-543.
47. Leão L. I., Ho P. L. & Junqueira-de-Azevedo I. L. (2009) Transcriptomic basis for an antiserum against Micrurus corallinus (coral snake) venom. BMC Genomics. 10: 112.
48. Leynaud G. C. & Reati G. J. (2009). Identificación de las zonas de riesgo ofídico en Córdoba, Argentina, mediante el programa SIGEpi. Rev. Panam. Salud Pública. 26: 64-69.
49. Manock S. R., Suárez G., Graham D., Avila-Agüero M. L. & Warrell D. A. (2008). Neurotoxic envenoming by South American coral snake (Micrurus lemniscatus helleri): case report from eastern Ecuador and review. Trans. R. Soc. Trop. Med. Hyg. 102: 1127-1132.
50. Ministerio da Saúde (1998). Manual de Diagnóstico e Tratamento de Acidentes por Animais Peçonhentos. Ministerio da Saúde. Brasilia, Brasil.
51. Ministerio de Salud (2007). Guía de Prevención, Diagnóstico, Tratamiento y Vigilancia Epidemiológica de los Envenenamientos Ofídicos. Ministerio de Salud. Buenos Aires, Argentina.
52. Ministerio de Salud Pública y Bienestar Social (2008). Manual de Procedimientos sobre Accidentes Ofídicos. Organización Panamericana de la Salud. Asunción, Paraguay.
53. Olamendi-Portugal T., Batiasta C. V., Restano-Cassulini R., Pando V., Villa-Hernández O., Zavaleta Martínez-Vargas A. et al. (2008) Proteomic analysis of the venoms from the fish eating coral snake Micrurus surinamensis: novel toxins, their function and phylogeny. Proteomics. 8: 1919-1932.
54. Otero R., Tobón G. S., Gómez L. F., Osorio R., Valderrama R., Hoyos D. et al. (1992). Accidente ofídico en Antioquia y Chocó. Aspectos clínicos y epidemiológicos (marzo de 1989-febrero de 1990). Acta Méd. Coloma. 17: 229-249.
55. Otero R., Núñez V., Osorio R. G., Gutiérrez J. M., Giraldo C. A. & Posada L. E. (1995). Ability of six Latin American antivenoms to neutralize the venom of mapaná equis (Bothrops atrox) from Antioquia and Chocó (Colombia). Toxicon. 33: 809-815.
56. Otero R., Gutiérrez J.M., Núñez V., Robles A., Estrada R., Segura E. et al. (1996). A randomized double-blind clinical trial of two antivenoms in patients bitten by Bothrops atrox in Colombia. Trans. R. Soc. Trop. Med. Hyg. 90: 696-700.
57. Otero R., Gutiérrez J. M., Rojas G., Núñez V., Díaz A., Miranda E. et al. (1999). A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of Ig G in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon. 37: 895-908.
58. Otero R., Gutiérrez J., Mesa M. B., Duque E., Rodríguez O., Arango J. L. et al. (2002). Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon. 40: 1107-1114.
59. Otero R., León G., Gutiérrez J. M., Rojas G., Toro M. F., Barona J. et al. (2006). Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans. R. Soc. Trop. Med. Hyg. 100: 1173-1182.
60. Otero-Patiño R. (2009). Epidemiological, clinical and therapeutic aspects of Bothrops asper bites. Toxicon. 54: 998-1011.
61. Otero-Patiño R., Cardoso J.L. C., Higashi H. G., Núñez V., Díaz A., Toro M. F. et al. (1998). A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. Am. J. Trop. Med. Hyg. 58: 183-189.
62. Otero-Patiño R., Silva-Haad J. J., Barona-Acevedo M. J., Toro-Castaño M. F., Quintana-Castillo J. C., Díaz-Cadavid A. et al. (2007) Accidente bothrópico en Colombia: estudio multicéntrico de la eficacia y seguridad de Antivipmyn-Tri®, un antiveneno polivalente producido en México. Iatreia. 20: 244-262.
63. Pardal P. P., Souza S. M., Monteiro M. R., Fan H. W., Cardoso J. L., França F. O. S. et al. (2004). Clinical trial of two antivenoms for the treatment of Bothrops and Lachesis bites in the north eastern Amazon region of Brazil. Trans. R. Soc. Trop. Med. Hyg. 98: 28-42.
64. Pierini S. V., Warrell D. A., de Paulo A. & Theakston R. D. G. (1996). High incidence of bites and stings esby snakes and other animals among rubber tappers and Amazonian Indians of the Juruá valley, Acre state, Brazil. Toxicon. 34: 225-236.
65. Prado-Franceschi J. & Hyslop S. (2002). South American colubrid envenomations. J. Toxicol. Toxin Rev. 21: 117-158.
66. Rahman R., Faiz M. A., Selim S., Rahman B., Basher A., Jones A. et al. (2010). Annual incidence of snake bite in rural Bangladesh. PLoS Negl. Trop. Dis. 4: e860.
67. Rodrigues-Silva R., Antunes G. F., Velarde D. T. & Santoro M. M. (1999). Thermal stability studies of hyperimmune horse antivenoms. Toxicon. 37: 33-45.
68. Rodríguez-Acosta A., Mondolfi A., Orihuela R. & Aguilar M. (1995). ¿Qué hacer frente a un accidente ofídico? Venediciones. Caracas, Venezuela.
69. Rojas E., Quesada L., Arce V., Lomonte B., Rojas G. & Gutiérrez J. M. (2005). Neutralization of four Peruvian Bothrops sp snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment. Acta Trop. 93: 85-95.
70. a ed. Sarvier, São Paulo, Brasil.
71. Saravia P., Rojas E., Arce V., Guevara C., López J. C., Chaves E. et al. (2002). Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications. Rev. Biol. Trop. 50: 337-346.
72. Saravia P., Rojas E., Escalante T., Arce V., Chaves E., Velásquez R. et al. (2001). The venom of Bothrops asper from Guatemala: toxic activities and neutralization by antivenoms. Toxicon. 39: 401-405.
73. Sasa M. & Vázquez S. (2003) Snakebite envenomation in Costa Rica: a revision of incidence in the decade 1990-2000. Toxicon. 41: 19-22.
74. Segura A., Herrera M., González E., Vargas M., Solano G., Gutiérrez J. M. et al. (2009). Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature. Toxicon. 53: 609-615.
75. Segura A., Castillo M. C., Núñez V., Yarlequé A., Gonçalves L. R. C., Villalta M. et al. (2010). Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon. 56: 980-989.
76. Serrano S. M. T., Shannon J. D., Wang D., Camargo A. C. & Fox J. W. (2005). A multifaceted analysis of viperid snake venoms by two-dimensional gel electrophoresis: an approach to understand venom Proteomics. Proteomics. 5: 501-510.
77. Smalligan R., Cole J., Brito N., Laing G. D., Mertz B. L., Manock S. et al. (2004). Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms. B. M. J. 329: 1129.
78. Tanaka G. D., Furtado M. F. D., Portaro F. C., Sant'Anna O. A. & Tambourgi D. V. (2010). Diversity of Micrurus snake species related to their venom toxic effects and the prospective of antivenom neutralization. PLoS Negl. Trop. Dis. 4: e622.
79. Teixeira C., Cury Y., Moreira V., Picolo G. & Chaves F. (2009). Inflammation induced by Bothrops asper venom. Toxicon. 54: 988-997.
80. Theakston R. D. G., Laing G. D., Fielding C. M., Lascano A. F., Touzet J. M., Vallejo F. et al. (1995). Treatment of snake bites by Bothrops species and Lachesis muta in Ecuador: laboratory screening of candidate antivenoms. Trans. R. Soc. Trop. Med. Hyg. 89: 550-554.
81. Thomas L., Tyburn B., Bucher B., Pecout F., Ketterle J., Rieux D. et al. (1995). Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Am. J. Trop. Med. Hyg. 52: 419-426.
82. Thomas L., Tyburn B. & Research Group on Snake Bite in Martinique (1996). Bothrops lanceolatus bites in Martinique: Clinical aspects and treatment. pp. 255-265. En: Envenomings and Their Treatments. Eds. Bon C. & Goyffon M. Fondation Marcel Mérieux, Lyon, Francia.
83. Vital Brazil O. (1987a). Coral snake venoms: mode of action and pathophysiology of experimental envenomation. Rev. Med. Inst. Med. Trop. São Paulo. 29: 119-126.
84. Vital Brazil O. (1987b) History of the primordia of snake-bite accident serotherapy. Mem. Inst. Butantan. 49: 7-20.
85. Warrell D. A. (2004). Snakebites in Central and South America: Epidemiology, clinical features, and clinical management. pp. 709-761. En: The Venomous Reptiles of the Western Hemisphere, vol I. Eds. Campbell J.A. & Lamar W.W. Cornell University Press. Ithaca, USA.
86. Williams D., Gutiérrez J. M., Harrison R., Warrell D. A., White J., Winkel K. D. et al. (2010). The Global Snake Bite Initiative: an antidote for snake bite. Lancet. 375: 89-91.
87. WHO (2007a). Rabies and envenomings. A neglected public health issue. World Health Organization, Geneva. Documento en línea: www.who.int/bloodproducts/animal-sera/Rabies.pdf) (Consultado: 2011, 7 de abril).
88. WHO (2007b). WHO Model List of Essential Medicines. WHO, Geneva. Documento en línea: www.who.int/medicines/publications/ essentialmedicines/en/index.html (Consultado: 2011, 7 de abril).
89. WHO (2010). Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins. WHO, Geneva. Documento en línea: www.who.int/bloodproducts/snakeantivenoms (Consultado: 2011, 3 de abril).